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INTRODUCTION
Endoscopic ultrasound 
(EUS) has progressed over the 
last years from a purely diagnostic 
tool into an interventional 
technique, allowing minimally 
invasive procedures that have 
gradually substituted previous 
approaches and become the 
standard of care. This is the 
case with the gallbladder, an 
area never explored before. 
The most frequent indication is 
gallbladder drainage in patients 
with acute cholecystitis unfit 
for surgery. The availability 
of dedicated lumen apposing 
meta l  s tents  (LAMS) has 
m a d e  t h e  i nte r ve nt i on a l 
EUS technically easier and 
inspired some interventional 
endosonographers to use the 
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ABSTRACT
Interventional endoscopic ultrasound (EUS) is a rapidly expanding field with a wide variety of indications, 
including different drainage procedures and delivery of locoregional treatment mainly for pancreatic solid 
tumors. Transgastric or transduodenal gallbladder drainage in high-risk patients with acute cholecystitis or 
biliary decompression in patients with unresectable distal biliary malignant obstruction who failed endoscopic 
retrograde colangiography is one of the newest areas of EUS-guided intervention. The large-caliber lumen 
apposing metal stents placed during these procedures allow direct endoscopic gallbladder access and the 
possibility of performing gallstone treatment or resection of mucosal polyps. The current review presents the 
indications of endoscopic gallbladder interventions and discusses the results of available studies, foreseeing 
future potential applications.
 
Key words: endoscopic ultrasound – biliary drainage – lumen apposing metal stent – acute cholecystitis.
Abbreviations: AE: adverse event; EUS: endoscopic ultrasound; ERCP: endoscopic retrograde cholangio-
pancreatography; ETD: endoscopic transpapillary drainage; LAMS: lumen apposing metal stents; LC: 
laparoscopic cholecystectomy; PT-GBD: percutaneous transhepatic gallbladder drainage.
same approach to decompress the biliary system in patients 
with unresectable distal biliary malignant obstruction and 
failed endoscopic retrograde cholangio-pancreatography 
(ERCP). The stable communication of the gallbladder with 
the stomach/duodenum created by LAMS with an inner 
diameter of 10 to 15mm allows cholecystoscopy performed 
with a gastroscope and, subsequently, gallstone removal or 
polyp resection.
The aim of this review is to present the current literature 
regarding EUS-guided gallbladder drainage procedures and 
the novel direct gallbladder endoscopic interventions.
Several databases (Medline, Embase, and Cochrane 
Central) were investigated. The search terms included 
“endoscopic ultrasound”, “acute cholecystitis”, “gallbladder”, 
“gallstones” and “cholecystostomy”. Articles were reviewed 
by title and abstracts by two independent reviewers (S.F.C., 
M.R.) and duplicates were removed. We selected the studies 
that evaluated the EUS approach for gallbladder drainage 
or for creating cholecysto-enteric communication allowing 
direct endoscopic access. Only English language articles were 
included.
The initial search identified 706 articles, of which 31 
comprised endoscopic gallbladder interventions. 
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EUS-GUIDED GALLBLADDER 
DRAINAGE FOR ACUTE CHOLECYSTITIS 
IN HIGH-RISK PATIENTS 
Laparoscopic cholecystectomy (LC) represents the gold 
standard for urgent treatment of acute cholecystitis. However, 
in critically ill patients, the surgical approach is associated with 
a significant risk of morbidity (up to 41%) [1, 2] and mortality 
(up to 19%) [3]. Therefore, in this setting, minimally-invasive 
alternative drainage procedures have been performed as a 
bridge to surgery or even as a definitive treatment. Currently, 
two options are worldwide established: ultrasound-guided 
percutaneous transhepatic gallbladder drainage (PT-GBD) 
[4] and endoscopic transpapillary stenting or drainage (ETD) 
[5]. Both approaches have several limitations. Despite a 
technical success of nearly 100%, PT-GBD is characterized by 
a significant rate of adverse events (AEs) (mean 6.2%, range 
0-25%, including intrahepatic hemorrhage, pneumothorax, or 
biliary peritonitis) [3] and a mortality that can be as high as 
17.5% in poor surgical candidates [6]. Furthermore, recurrent 
cholecystitis or inadvertent tube dislodgement and migration 
requiring repetition of the PT-GBD procedure occur in up 
to 12% of cases [3]. Last but not the least, the percutaneous 
catheter determines a significant degree of discomfort and 
local pain for the patient [3]. The ETD has a technical success 
rate of about 80% [7]. The main difficulty is related to the 
selective guide-wired cannulation of the cystic duct. It is 
often technically challenging and time-consuming given the 
angulation of the cystic duct takeoff, often associated with a 
narrowing of cystic duct orifice from edema, obstruction by 
stones or tumor, besides its valves and tortuosity. After the 
guide-wire is coiled in the gallbladder, the cystic duct dilation 
with a 6-Fr or 8-Fr dilator can be performed before placing 
a plastic double pigtail biliary stent (usually with a caliber of 
7-Fr) with a pigtail into the gallbladder and the other into the 
duodenal lumen, across the ampulla. In addition to technical 
difficulties, the clinical response rate of ETD is not higher 
than 75% with an incidence of procedure-related AEs ranging 
between 0 to 14% [7]. 
Since 2007, EUS-guided transmural gallbladder drainage 
(EUS-GBD) has been proposed as an alternative treatment 
to the previous minimally-invasive techniques [8]. Several 
retrospective and prospective studies have been published 
reporting the feasibility and safety of the procedure both 
using conventional drainage devices (nasobiliary drainage, 
plastic stents, or self-expandable metal stent - SEMS) or LAMS 
[8-20]. In the initially described technique, the gallbladder 
was punctured using a FNA needle, then a 0.035- or 0.025-
inch guidewire was inserted, and the fistula tract dilated 
using a 4mm balloon or a tapered catheter. Sometimes an 
electrocautery device (e.g., a needle-knife) had to be used to 
definitely allow the stent-delivery passage. Finally, conventional 
drainage devices (plastic double pigtails, SEMS, or nasobiliary 
drainage) were inserted. Despite a theoretically increased 
risk of bile leakage compared with SEMS, in the case of EUS-
GBD performed as a “bridge to surgery” or in patients likely 
to undergo LC after transmural drainage, plastic stents or 
nasobiliary drainage should be preferred and should be placed 
transgastrically when possible. Indeed, in the study of Jang et al. 
[11], 23 patients underwent cholecystectomy after EUS-GBD 
performed with plastic devices and no adhesions between the 
gallbladder and the surrounding tissue complicated the surgical 
procedure [11]. Compared with plastic stents, standard SEMS 
are associated with longer patency and could reduce the risk 
of a bile leak. However, stent migration can occur with SEMS 
not designed for this type of procedure. To prevent SEMS 
migration, an additional double pigtail plastic stent can be 
inserted through the SEMS [12, 13, 15]. Overall, this “initial” 
technique was used in about 220 patients, with a clinical success 
of 95% and a 7% AEs rate [8-16].
The recently available LAMS, specifically designed 
to juxtapose two hollow organs/cavities to create a stable 
anastomosis/fistula tract, has represented a technical 
advancement for EUS-GBD, with the advantages of a decreased 
risk for bile leak and stent migration due to the shape of the 
flanges of these stents [17-21]. Different types of LAMS with 
different shapes are currently available (Fig. 1). Moreover, 
the large caliber of the LAMS (10 mm or more) allows better 
drainage, making the procedure more effective and definitive. 
In addition, the LAMS mounted on a delivery system with 
a cautery device at its tip (Hot-Axios™, Boston Scientific, 
Marlborough, Massachusetts, USA) has provided an additional 
advantage, rendering the procedure faster and easier to be 
accomplished. Indeed, a single step procedure without the need 
for accessory exchange can be done (Fig. 2). A recent meta-
analysis including 13 studies on 233 patients demonstrated an 
overall clinical success of 92.5% and an AEs rate of 18% [22]. 
Moreover, a systematic review with pooled analysis published 
in 2016 suggested a lower rate of AEs by using LAMS compared 
with plastic stents [23].
Fig. 1. Lumen-apposing or bi-flanged self-expandable metal stents 
that were studied for EUS-guided gallbladder drainage. A) The 
Spaxus™ stent; B) The NAGI™ stent; C) The AXIOS™ stent which can 
be mounted on and inserted with an electrocautery-enhanced delivery 
system [images courtesy of: A-B) Taewoong Medical Co., Ltd.; C) 
Boston Scientific Corp].
Regardless of the type of stent, EUS-GBD can be carried out 
by puncturing the gallbladder from the stomach or from the 
duodenum. The access site is usually chosen according to the 
best visualization of the gallbladder with the shorter distance 
from the gastrointestinal wall. Moreover, if the procedure is 
performed as a “bridge to surgery” the transgastric route is 
preferred because the stomach can be easily sealed during 
a cholecystectomy in case of adherence, while for definitive 
treatment the transduodenal route should be used to avoid 
reflux of the bile in the stomach and in the esophagus. No 
difference in overall technical, clinical success, and adverse 
events rate has been observed between the two access sites [16, 
24]. However, due to the reduced mobility of the duodenum 
compared with the stomach, the risk of stent migration 
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is theoretically lower with the transduodenal approach. 
Moreover, food impaction is less likely to occur when the 
procedure is performed from the duodenum. On the other 
hand, the large body of the gallbladder is usually visualized 
from the stomach and is easier to be punctured compared 
with the smaller gallbladder neck normally visualized from 
the duodenum. Furthermore, if a perforation occurs during 
EUS-GBD, the subsequent surgical management is easier when 
the procedure is performed from the stomach. 
Whether and when the stent, especially SEMS or LAMS, 
should be removed is unknown. In the study of Choi et al. 
[12] evaluating long-term outcomes after EUS-GBD in 56 
patients, the median stent patency was 190 days and the rate 
of late AEs was 7%. The decision to remove or leave in place 
the stent should be strictly related to the life expectancy of the 
patients [14, 20]. In patients with short-term survival (e.g., with 
advanced malignancy or severe comorbidities) the stent could 
be left in place to avoid the discomfort of a repeated procedure 
for stent removal [20]. Conversely, when survival is likely to 
be longer, stent removal should be considered to reduce the 
risk of late adverse events (i.e., stent migration, bleeding, tissue 
overgrowth, stent disfunction) [14]. In these cases, SEMS can 
be exchanged with a plastic double pig-tail stent for safety 
reasons and to further reduce the risk of recurrent cholecystitis.
EUS-GBD  VERSUS PT-GBD FOR ACUTE 
CHOLECYSTITIS
So far, there have been no good quality studies published 
comparing EUS-GBD and PT-GBD (Table I). Jang et al. [11] 
published a first comparative study in 2012 involving 59 
patients who were randomized in two arms (30 in EUS-GBD 
and 29 in PT-GBD). EUS drainage was performed by placing 
a 5-Fr nasobiliary drainage after puncturing the gallbladder 
with a 19G needle and dilating the tract with a 6-Fr dilator. 
The reported technical success rate was 97% in both arms, and 
the clinical success rate was 100% for EUS-guided drainage 
versus 97% for PT-GBD. However, in patients who underwent 
EUS-guided drainage, a significant decrease in the median 
post-procedural pain score was observed (1 vs. 5, p < 0.001). 
The described technique needs several devices exchange 
over the guidewire, which in non-expert hands could result 
in failures and in AEs. Moreover, in this study the majority 
of patients underwent gallbladder drainage as a “bridge” to 
cholecystectomy, thus the follow-up period was extremely 
short (less than two weeks) to fully assess long-term post-
procedural AEs. 
In 2017, Choi et al. [25] published a study comparing 
EUS-GBD and PT-GBD in patients with malignant cystic 
duct obstruction. This was a retrospective single center study 
involving 14 patients with acute cholecystitis or symptomatic 
gallbladder hydrops, in which EUS-GBD was performed by 
placing a transmural SEMS using a 19G needle and a dilator 
before stent delivery, similarly to the technique described by 
Jang et al. [10]. Nineteen patients treated with PT-GBD were 
used as a control group. Technical and clinical success in the 
EUS-GBD group was 85.7% and 91.7%, and in the PT-GBD 
group 100% and 86.4%, respectively, with no statistically 
significant differences. Similar AEs rate (28%) for the two 
groups was observed after a median follow-up of 60 days. 
Conclusions, however, were limited by the small sample size, 
retrospective design, and utilization of SEMSs not specifically 
designed for this type of procedure, thus potentially accounting 
for some AEs and cholecystitis recurrence. 
Currently, two retrospective studies comparing EUS-GBD 
with LAMS and PT-GBD are available [24, 26]. The first one is 
a 1:1 matched cohort study, in which both the device without 
or with the cautery tip (the Axios™ and the Hot-Axios™, Boston 
Scientific, Marlborough, Massachusetts, USA) were used for 
EUS-GBD and compared to PT-GBD [24]. The study included 
59 patients per group, but the overall follow-up period was not 
reported. Technical and clinical success rates were comparable, 
Fig. 2. EUS-guided drainage using a lumen-apposing metal stent (LAMS) in a 
patient with acute cholecystitis with multiple co-morbidities unfit for surgical 
cholecystectomy. A) Endoscopic ultrasound appearance of the gallbladder, 
which presents an obviously thickened wall (arrows); B) EUS-guided puncture 
of the gallbladder with a 19-gauge needle (arrow), through which a guidewire 
was inserted (arrowheads); C) Over-the-guidewire insertion of a LAMS; in this 
step the distal flange was deployed (arrow); D) After proximal flange (arrow) 
was deployed inside the duodenum: pus is seen draining from the gallbladder.
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but in the EUS-GBD group fewer patients suffered from overall 
AEs (32 % vs. 75%, p < 0.001) and serious AEs (24 % vs. 75%, p 
< 0.001) compared to the PT-GBD group. Some biases could 
account for these results as suggested by such a high rate of AEs 
in the PT-GBD group as compared with the literature. Patients 
in the EUS-GBD group required fewer unplanned admissions 
(7 % vs. 71 %, p < 0.001), which in 95 % of cases were due to 
problems related to the cholecystostomy tube in the PT-GBD 
arm. Acute cholecystitis recurred in 4 (6.8 %) patients treated 
by PT-GBD and in none in the EUS-GBD group (p =  0.12). 
However, the 30-day mortality rate was higher in the EUS-
GBD group (5 patients [8.5 %] vs. 1 patient [1.7 %]) but was not 
statistically significant (p  =  0.21). In this study, the authors for 
the first time used a specific follow-up schedule for EUS-GBD 
patients who underwent cholecystoscopy 12 weeks after the 
procedure using a standard endoscope through the previously 
placed LAMS, to check for residual stones and if necessary, to 
perform lithotripsy until complete clearance. Once clearance 
was obtained, the LAMS was exchanged for a plastic stent.
The second study is a multicenter retrospective study in 90 
high-risk surgical patients with acute cholecystitis (45 managed 
by EUS-GBD and 45 by PT-GBD) [26]. As in the previous 
study, cautery and non-cautery LAMS were used. Technical and 
clinical success rates were comparable between the two groups 
(89% vs. 100%, and 96% vs. 91% for EUS-GBD and PT-GBD, 
respectively). Fewer AEs occurred in the EUS-GBD group 
(8 vs. 14, p = 0.07), with no differences in severity or deaths. 
Post-procedural pain scores were lower in the EUS-GBD group 
(p < 0.05), as well as the length of hospital stay (3 days vs. 9 
days, p < 0.05) and the need for repeated interventions (11 vs. 
112, p < 0.01).
Finally, another retrospective study by Tyberg et al. [16] 
compared EUS-GBD performed using different types of SEMS 
with PT-GBD. Comparable outcomes for EUS-GBD and PT-
GBD regarding technical and clinical success and the rate of 
immediate and delayed AEs were found.
Recently, a meta-analysis compared the outcomes of 298 
patients treated by PT-GBD and 206 patients who underwent 
EUS-GBD [27]. No statistically significant differences both 
in technical and clinical success were observed. However, 
patients in the EUS-GBD group experienced fewer AEs, had 
shorter hospital stay with fewer readmissions, and required 
less frequently reinterventions [27].  
EUS-GBD VERSUS ETD FOR ACUTE 
CHOLECYSTITIS
Regarding ETD versus EUS-GBD, two studies were recently 
published [28, 29]. The first study including 172 patients (76 
EUS-GBD and 96 ETD) showed in the EUS-GBD group 
significantly higher technical and clinical success rates (99% 
vs. 83%, and 99% vs. 82%, respectively, p < 0.01), a better safety 
profile (procedure-related AEs after statistical adjustment of 
7% vs. 19%, p = 0.02) and lower post-procedural cholecystitis 
and cholangitis rates (3% vs. 12%, p = 0.04) [28]. In the second 
one, EUS-GBD was performed in 40 patients by using a LAMS 
(both with electrocautery and nonelectrocautery tip) whereas 
38 patients underwent ETD with a 7-Fr double pigtail stent. 
As in the first study, technical and clinical success were higher 
in the EUS-GBD group compared with the ETD group (97% 
vs. 84%, and 95% vs. 76%, respectively). Moreover, the rate of 
recurrent cholecystitis was significantly lower after EUS-GBD 
(2.6% vs. 18.8% in the ETD group) [29].
A three-way retrospective study comparing EUS-GBD 
vs. PT-GBD vs. ETD is also available [30].  In this study, 372 
patients were included (146 by PT-GBD, 124 by ETD, and 
102 EUS-GBD). Technical and clinical success rates were 
significantly higher for PT-GBD and EUS-GBD (98% vs. 
Table I. Summary of studies comparing percutaneous with endoscopic ultrasound-guided gallbladder drainage

























































































































































LAMS: lumen-apposing metal stent; PS: plastic stent; SEMS: self-expanding metal stents; *Both electrocautery-enhanced and nonelectrocautery-enhanced.
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88% vs. 94%, p = 0.004; and 97% vs. 90% vs. 80%, p < 0.001, 
respectively). Significantly higher post-procedural AEs rate 
and additional surgical interventions were reported for PT-
GBD (20% vs. 2% vs. 5%, p = 0.01; and 49% vs. 4% vs. 11%, p 
< 0.0001, respectively) [30]. Outcomes of studies comparing 
EUS-GBD with ETD are summarized in Table II.
EUS-GBD AS AN ALTERNATIVE ROUTE 
FOR BILIARY DECOMPRESSION
In patients with unresectable malignant distal biliary 
obstruction and a patent cystic duct communicating with the 
obstructed biliary system, drainage of the gallbladder appears a 
viable alternative of biliary drainage in case of failures of ERCP 
[31]. In this clinical setting, EUS drainage can be more easily 
performed through the gallbladder than the dilated bile duct, 
due to gallbladder distension with a large surface superficially 
located, with generally no interposing structures with the 
gastric or duodenal wall. Careful examination to exclude 
cystic duct involvement prior to performing the drainage is 
mandatory, as is intraprocedural cholangiogram.
Only one small study on 12 patients evaluated EUS-GBD 
for this indication and reported technical and clinical success 
for biliary drainage in 100% and 91.7% of cases [32], promoting 
this technique as potentially useful for cases with previously 
failed ERCP and a patent cystic duct. In this situation, where 
drainage is left in place indefinitely, the transduodenal route is 
favoured over the transgastric one, because it avoids bile reflux 
through the stomach into the esophagus.
DIRECT ENDOSCOPIC GALLSTONE 
TREATMENT
Removal of gallstones, the most common cause of 
cholecystitis, seems feasible once the gallbladder has been 
accessed (Fig. 3). The wide opening of the currently available 
LAMS offers an “open door” for most of the stones to naturally 
leave the gallbladder and provides a second drainage route 
for the bile secretions in case of cystic duct blockage. When 
large stones are retained in the gallbladder and cannot be 
removed using Dormia baskets, despite balloon dilation of 
the mid portion of the stent, access of the gallbladder with a 
standard endoscope and intraluminal lithotripsy either with 
holmium laser or mechanical devices can be done [33]. Stone 
fragments can be flushed out or removed from the gallbladder 
using a polypectomy retrieval basket until complete clearance 
is obtained, as previously shown [34]. This is relevant given the 
potential risk of recurrent cholecystitis due to residual stones 
impaction in the stent. Once clearance has been obtained, 
LAMS can be removed using a snare or grasping forceps and 
the fistula tract completely closed using an over-the-scope clip 
[33] or standard clips [35].
Table II. Summary of studies comparing endoscopic transpapillary with endoscopic ultrasound-guided gallbladder drainage
























































































SEMS: self-expanding metal stents; LAMS: lumen-apposing metal stent. *Both electrocautery-enhanced and nonelectrocautery-enhanced.
Fig. 3. Direct endoscopic gallbladder stones removal. A) The gallbladder lumen (*) 
is visible through a lumen-apposing metal stent (LAMS) previously placed under 
EUS-guidance creating a cholecysto-gastrostomy. B) The cholecysto-gastrostomy 
is entered with an endoscope depicting the regular aspect of the gallbladder 
mucosa (*) and gallbladder stones (¶). C) Gallbladder stones (white arrow) being 
extracted with a Dormia basket (black arrow) through the lumen of the LAMS.
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ENDOSCOPIC GALLBLADDER MUCOSA 
IMAGING
Once the gallbladder has been accessed, the available 
technologies already implemented for regular endoscopy can 
be applied for mucosa examination. Virtual chromoendoscopy 
techniques can be used to inspect for neoplastic tissue 
detection. Confocal imaging, cholangioscopy or high frequency 
miniprobes for intraluminal ultrasound can also be used to 
examine the gallbladder mucosa. Only initial reports have been 
published so far [34], and the detection of early gallbladder 
mucosal neoplasia remains challenging. A histology study 
reported that none of the 37 cases with suspected dysplasia 
at gallbladder mucosa examination was confirmed at the 




Gallbladder polyp prevalence can reach 9.5% [37]. 
However, up to 70% of suspected gallbladder polyps are 
pseudopolyps (cholesterol or inflammatory pseudopolyps 
or focal adenomyomatosis) with no malignant potential 
[38]. True polyps are generally adenomas but, in contrast to 
colonic polyps, the adenoma-carcinoma sequence is not well 
established. The low incidence of gallbladder adenomas and 
the presence of adenomatous remnants in the mucosa close 
to early carcinomas in less than 3% of the cases suggest the 
limited importance of this carcinogenic pathway [39]. Current 
guidelines recommend LC for large (>10mm) polyps, or for 
middle-sized polyps (6-9mm) in high-risk patients (age >50 
years, Indian ethnicity, primary sclerosing cholangitis, sessile 
polyps) [40]. Surgery is also indicated in symptomatic patients 
because polyps can be indicative of underlying inflammation 
or cholelithiasis [40]. 
In 2011, Chen et al. [41] reported the first case of 
endoscopic gallbladder polypectomy through a previously 
performed surgical cholecysto-gastrostomy [41]. EUS-
guided cholecysto-gastrostomy or cholecysto-duodenostomy 
with large lumen through LAMS makes possible the direct 
endoscopic polypectomy. In 2016, Ge et al. [42] reported a 
small case series of EUS-GB access using a LAMS followed by 
gallstones removal in seven cases and gallbladder polypectomy 
in two cases. Recently, Tian et al. [35] described another case 
of successful gallbladder polypectomy of three polyps through 
an electrocautery-enhanced LAMS. In this case, authors had to 
remove the LAMS before the last polypectomy because of the 
difficult visualization and the limited operating space. 
A possible advantage of endoscopic polypectomy is that 
no incision in the abdominal wall is necessary, offering better 
cosmetic results as compared to LC. Another theoretical 
advantage of the EUS approach is the preservation of the 
gallbladder. However, the long-term rate of polyps recurrence 
is unknown, thus repeated endoscopic treatment could be 
required over time. Moreover, it is unknown if the gallbladder 
wall can sustain a polypectomy in all cases.
Endoscopic gallbladder polypectomy through an EUS-
guided cholecysto-enterostomy should at present be offered 
only when cholecystectomy is absolutely contraindicated, in 
patients who refuse surgery, or in those in whom EUS-GBD 
has been already performed for acute cholecystitis treatment 
and the presence of polyp(s) disclosed after the procedure. In 
all these cases, whenever possible, it could be convenient to 
perform the drainage of the gallbladder from the stomach to 
avoid formation of adherence from the gallbladder wall and the 
duodenum, which can make a subsequent surgical intervention 
more difficult.
DISCUSSION
Based on current evidence from the available studies, 
advantages of EUS-GBD over the percutaneous approach 
are mainly in terms of quality of life, the decreased need for 
repeat procedures, and the capability of solving the cause of 
the cholecystitis. However, because of the retrospective design 
of the available comparative studies, no definitive conclusions 
can be drawn, and randomized controlled trials are desperately 
needed. With regard to the latter, a randomized study 
(NCT01146743) was completed several years ago, but results 
are not yet available. Hopefully, further evaluations will come 
from another randomized trial comparing PT-GBD and EUS-
GBD that is still ongoing (NCT02212717). Up to now, based 
on the conclusions of the Tokyo guidelines on management 
strategies in patients with acute cholecystitis, EUS-GBD should 
be considered in high-volume centers when performed by 
skilled echoendoscopists (level of evidence B) [43].
At present, the main indication for EUS-GBD is acute 
cholecystitis in high-risk surgical patients [44], but a number 
of different EUS-guided gallbladder interventions could be 
foreseen for the near future, as already discussed. However, 
little is known about the long-term consequences of creating 
a cholecysto-enteric anastomosis. Alterations in the normal 
physiological functions of the gastrointestinal tract might 
result in long-term effects on the gastrointestinal and biliary 
mucosal surfaces. One representative case attributed to 
cholecystectomy is the increased risk of colorectal cancer 
[45]. Likewise, a cholecysto-gastro-anastomosis, with the 
bile flowing into the stomach, might theoretically lead to bile 
gastritis and an increased risk of gastric cancer, similarly to 
what is observed in patients with Billroth II anastomosis [46]. 
Moreover, gallbladder mucosa might be injured by the reflux 
of enteric content, and recurrent cholecystitis might represent 
a long-term complication in patients with cholecysto-enteric 
anastomoses. In the case of cholecysto-enterostomy, the 
passage of food into the gallbladder is considered inevitable [47, 
48] and this might predispose to cholecystitis and cholelithiasis. 
Regarding recurrence of acute cholecystitis after EUS-GBD, 
in a small retrospective study it was observed in 1/13 patients 
(7.7%) after a median follow up of 240 days [49]. In another 
larger retrospective study on 56 patients followed for a median 
of 275 days after EUS-GBD, acute cholecystitis recurred in 2 
patients (3.6%) due to stent occlusion [12], while in a study 
using LAMS, after a mean follow-up period of 298 days, 7% of 
the patients developed recurrent cholecystitis [20].
Looking into the surgically created gallbladder anastomoses, 
in a retrospective study of 34 patients with cholecysto-
enterostomy for benign biliary obstruction over a 17-year 
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period, five  patients (15%) experienced recurrent biliary stones 
after a mean follow up of 8 years (which is the longest reported 
so far) [50]. In the same study, biliary obstruction in four cases 
and anastomotic stricture in one case occurred [50]. In another 
report, there were five cases of recurrent cholangitis occurring 
between two to nine years after cholecysto-enteric bypass [51]. 
Three of these patients required repeat surgery, and chronic 
inflammation at the anastomosis site was pathologically 
proven. No patient developed biliary tract or gastrointestinal 
tract malignancy in these reports [50, 51].
Regarding the neoplastic risk after gallbladder-enteric 
anastomosis, the available evidence is far more limited. If 
we refer to biliary-enteric anastomoses in general, there is 
experimental, clinical, and epidemiological data available to 
support the risk of cholangiocarcinoma [52-54]. It developed 
in 5.5% of a cohort of 1,003 patients with biliary-enteric 
anastomoses collected over a 30-year period [55]. The risk 
was higher in patients with choledocho-duodenostomy 
than in those with transduodenal sphincteroplasty or 
hepatico-jejunostomy (7.6% vs. 4.8% vs. 1.9%, respectively). 
Interestingly, it has been found that only patients who had 
recurrent bouts of cholangitis developed cholangiocarcinoma 
[56], linking infection and inflammation to neoplasia 
development. Likewise, irritation of the gallbladder mucosa 
could predispose to gallbladder carcinoma when anastomoses 
involving this organ are performed and left in place, but so far 
only two patients who developed gallbladder carcinoma 11 
and 22 years after cholecysto-jejunostomy have been reported 
[57, 58].
All the above considerations seem to have little impact in 
high-risk surgical patients, in whom life expectancy is limited, 
while they need to be considered in studies designed to widen 
the indications for EUS-guided cholecystostomy.
CONCLUSION AND FUTURE 
DIRECTIONS
EUS-guided cholecystostomy is steadily gaining its place 
as a definitive treatment or a bridge to surgery in high-risk 
surgical patients with acute cholecystitis and might become 
soon the standard of care in this clinical setting when results 
of randomized trials become available. These results will be 
the basis for future studies in patients with less strict inclusion 
criteria and compared with LC in patients who are fit for 
surgery. In malignant unresectable distal biliary obstruction, 
EUS-GBD could also represent a viable option, but more data 
are needed. Finally, minimally invasive creation of a colecysto-
enteric anastomosis that could allow endoscopic clearance of 
gallbladder stones, careful exploration of the mucosa with state-
of-the-art endoscopic imaging modalities, and endoscopic 
resection of gallbladder polyps is without any doubt very 
attractive. However, in cases in which definitive cholecysto-
enterostomy needs to be created, a balance between the benefit 
of the procedure with the long-term risks of malignancy has 
to be carefully considered. We believe that the beauty is in 
the eye of the beholder and the future of this procedure looks 
extremely bright.
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